AffiliationCRC Department of Epithelial Biology, Paterson Institute for Cancer Research and Department of Surgery, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK.
MetadataShow full item record
AbstractStem cell research provides a foundation for therapeutic advancement in oncology, clinical genetics and a diverse array of degenerative disorders. For example, the elucidation of pathways governing proliferative regulation and differentiation within cellular systems will result in medical strategies aimed at the root cause of cancer. At present the characterization of reliable stem cell markers is the immediate aim in this particular field. Over the past 30 years investigators have determined many of the physical and functional properties of stem cells through careful and imaginative experimentation. Intestinal stem cells reside at the crypt base and give rise to all cell types found within the crypt. They readily undergo altruistic apoptosis in response to toxic stimuli although their progeny are hardier and will regain stem cell function to repopulate the tissue compartment, giving rise to the concept of a proliferative hierarchy. Contention exists when deciding whether the full complement of cells within a crypt is derived from either a single or multiple stems. Evidence has also arisen to challenge the long held view that colorectal tumours arise from a single mutated stem cell, as early adenomas from a human XO/XY mosaic contained distinct clones. Mechanisms governing the stem cell cycle and subsequent proliferative activity largely remain obscure. The adenomatous polyposis coli gene product has, however, been shown to promote the degradation of beta-catenin, an enhancer of cell proliferation, thereby downregulating this activity in healthy individuals.
CitationStem cells: the intestinal stem cell as a paradigm. 2000, 21 (3):469-76 Carcinogenesis
- Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
- Authors: Wong MH, Huelsken J, Birchmeier W, Gordon JI
- Issue date: 2002 May 3
- Mechanisms of disease: from stem cells to colorectal cancer.
- Authors: McDonald SA, Preston SL, Lovell MJ, Wright NA, Jankowski JA
- Issue date: 2006 May
- Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
- Authors: Zahner G, Wolf G, Ayoub M, Reinking R, Panzer U, Shankland SJ, Stahl RA
- Issue date: 2002 Mar 22
- [COX-2 associated loss of apoptosis activity in intestinal neoplams in Apc gene knock-out mice].
- Authors: Schmehl K, Jacobasch G, Buhr HJ
- Issue date: 1998
- Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1).
- Authors: Cheng T, Shen H, Rodrigues N, Stier S, Scadden DT
- Issue date: 2001 Dec 15